Skip to content

NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA)
 SIGN THE PETITION

Researcher

Luca Marsili

After completing my residency training in Neurology in Italy, I pursued a PhD in Clinical Neuroscience, which solidified my commitment to both clinical practice and research in the field of movement disorders. Throughout this period, my work focused on three key areas: (a) the clinical phenomenology and genetic underpinnings of Read More…

Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.